Investor Ideas Potcasts #522, Cannabis News and Stocks on the Move (TSX: VLNS) (CSE: HOLL) (CSE: HARV) (CSE: CURA)
Delta, Kelowna, BC - January 25, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts #522, Cannabis News and Stocks on the Move (TSX: VLNS) (CSE: HOLL) (CSE: HARV) (CSE: CURA)
Today's podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today' s podcast we will be looking at a few public company announcements.
The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) announced that it has entered into a definitive agreement to acquire all of the issued and outstanding shares of LYF Food Technologies Inc. in a cash and share transaction for closing consideration of CDN$24.9 million, plus up to an additional CDN$17.5 million in consideration payable upon the business achieving certain earn-out EBITDA milestones. The LYF Acquisition is expected to be accretive to the Company's EBITDA and diluted EPS in 2021, and if all of the Milestones are met, the transaction represents an approximate ~4.2x multiple on the last milestone achieved. With the LYF Acquisition, The Valens Company not only strengthens its already wide-reaching production capabilities for the 2.0 and 3.0 markets, but also unlocks significant growth potential with the addition of a cutting-edge platform designed to capitalize on one of the fastest growing product segments in the cannabis industry.
LYF is a premier edibles manufacturer based in Kelowna, British Columbia with expertise in novel product creation, white label manufacturing and infusion technologies. Similar to Valens, LYF operates a product development and manufacturing platform focused on consumer-driven innovation, and product safety and consistency. LYF brings a proven team with significant experience producing high throughput food products, in addition to experience operating and working with major Canadian grocery chains, health and wellness retailers, and pharmacies. Just minutes away from Valens' headquarters, LYF's purpose-built manufacturing facility produces innovative edible products using the highest quality ingredients and cannabis extracts, offered in proprietary delivery methods.
Valens' access to low-cost active ingredients paired with LYF's industry-recognized product IP formulations of over 100 recipes strengthens its capabilities to produce higher-margin, new-to-market edible formats in a segment with limited product variability, and increased consumer demand. With the added infrastructure and expertise from the LYF Acquisition, The Valens Company significantly expands its edibles footprint and strategy to remain a best-in-class manufacturing platform for its partners, while also increasing its ability to capture market share in the rapidly growing product category. Similar to consumer trends in the US cannabis market, edible products are anticipated to represent over 10% of sales in the maturing Canadian cannabis market.
Tyler Robson, Chief Executive Officer and Chair of the Board of The Valens Company, said, "LYF has set the standard of what high quality edibles should be and has developed a diverse and flexible manufacturing platform to play a dominant role in the Canadian edibles market. LYF stood out for its product innovation and marketing teams, as well as its broad range of edible products which will introduce new formats to Canadian consumers that are typically only available in more mature markets. We look forward to further developing our product offering to reach more consumers with high-quality and unique cannabis edibles as this product segment continues to gain in popularity."
"Our team could not be more thrilled to join forces with The Valens Company and collectively fuel our shared passion for producing exceptional cannabis products with consumers top of mind," said Paolo Pero and Matthew Amado, Founders of LYF. "As a fellow Kelowna-based company, Valens' vision for global growth resonated with the team and ultimately led us to recognize the significant value in combining what we have each uniquely created to bring a new level of manufacturing excellence to Canada and beyond."
Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF), diversified cannabis branding company with products in over 98 dispensaries throughout Arizona, commended the state of Arizona for its efficient activation of adult-use cannabis sales. Legal sales of adult use cannabis in Arizona commenced mid-day on Friday January 22nd, 2021, several months ahead of industry expectations, and the fastest that any of the 15 states with recreational marijuana has gone from voter approval to actual sales.
The company's wholly owned subsidiary, Venom Extracts product suite is a category leader with over 4 million grams sold in 2020, accounting for up to 30 percent of category sales state-wide. Venom is positioned for continued growth in Arizona, it has a strong brand recognition and distribution network, its products are available at leading retailers including Harvest Health and Recreation (CSE: HARV) (OTCQX: HRVSF), Curaleaf (CSE: CURA) (OTCQX: CURLF), Bloom, MuV and Oasis Cannabis dispensaries among others.
Arizona voted to legalize adult use cannabis in November, "Marijuana Business Daily projects that the state's recreational market could generate up to $400 million in revenue its first year and more than $700 million by 2024".
"Medical-marijuana dispensaries that got approved to sell recreational marijuana on Friday include 13 of the 15 Harvest shops in the state, all eight Curaleaf shops, The Mint locations in Guadalupe and Mesa, three Territory Dispensary locations, and dozens of others in places across the state, including in Tucson, Yuma, Flagstaff, Cottonwood and Sedona. Arizona Department of Health Services spokesman Steve Elliott said Friday that the department had approved 86 applications. Some dispensaries in the state are still waiting to file their applications because they are not yet prepared to offer recreational sales, which are expected to bring substantially more traffic to their stores". As reported by AZ Central on January 22nd, 2021.
In 2020, sales of medical cannabis in Arizona grew by greater than 27%, as such Venom has been a catalyst for revenue growth of the Company. On March 26th, 2020 (see press release dated March 30th, 2020), Hollister Biosciences acquired Venom Extracts and since the closing, in the three quarters following, Venom contributed approximately CDN$38 million to the company's 2020 revenue. In the entire year of 2020, Venom Extracts generated greater than CDN$ 40 million in revenue (and CDN$4.8 million in adjusted EBITDA), up from CDN$16.4 million in 2019 a 144% year over year increase, and ending the year with a record month of sales for December totaling approximately CDN$5.5 million. These unaudited numbers represent record sales for the company, and the expectation is that sales growth will continue in 2021.
In addition to continued revenue growth, the company plans to focus on core growth area's including; enhancing; unit margins, market penetration, loyalty and same-store sales.
Some additional highlights of the company include:
- Branded Products now on sale in over 370 cannabis dispensaries in Arizona and California
- 4 owned brands, and 3 brand collaborations
- Over 4 million grams sold
- Over 96,000 lbs. of cannabis biomass converted into finished products in Arizona
- Total sales for 2020 increased 3233% from 2019 and are estimated to be approximately CDN $40 million
- December 2020 sales totaled greater than CDN$6 million
The Company looks forward to continuing execution of its business plan and growth targets in 2021, primarily focused on the exponential growth anticipated in and continued market penetration of branded products throughout California.
Global Trac Solutions, Inc. (OTC: PSYC), a digital media leader within the emerging sector of medicinal psychedelics, announced that the Company has entered into a Joint Venture Partnership with Minerco, Inc. (OTC: MINE), a Jamaican-based company specializing in growing, research, production and distribution of psilocybin mushrooms and marketing worldwide.
The JV creates an opportunity for the companies to collaborate on the co-development and hosting of virtual conferences and forums focused on educating, informing, and showcasing the potential medicinal benefits of psilocybin mushrooms, including the psilocybin-based products MINE is developing. Additionally, the JV allows for PSYC to serve as one of the primary digital marketing partners for MINE as they move forward with their focus of bringing their products to market.
"We are extremely delighted to partner with MINE, a company that is deeply-rooted in the sector of psilocybin mushrooms," said Global Trac Solutions, Inc. CEO, David Flores. "And we' re thrilled to be able to combine our collective resources to develop and produce virtual conferences and forums in the coming months that we believe will effectively highlight this exciting sector within the psychedelic industry."
"To JV with PSYC will be a great opportunity for both companies," said Julius Jenge, Minerco, Inc. CEO. "MINE will have the ability to do real case studies using our own product and PSYC will be able to track the research with their media platform. This initiative will allow us to host forums with both industry experts and patients who will give real examples of the benefits of Psilocybin and more specifically MINE products."
The companies intend to be able to collectively develop and produce their first joint virtual conference/forum within the next two months and will release more information to the public related to specific dates and times as soon as it is available.
"As our industry continues to gain more exposure and develop more momentum behind it, I believe we will continue to see an increase, globally, for platforms, such as Psychedelic Spotlight, that provide access to a wealth of informational and educational resources focused on this paradigm shift in healing and treatment that psychedelics like psilocybin are creating," Flores said. "As MINE continues its focus on developing quality psilocybin-based products, we here at PSYC look forward to leveraging our expanding media platform and network to contribute to their growth and success in the months to come."
CannabizTeam, the world's largest cannabis-focused executive search and staffing firm, has launched a new service line for cannabis companies: CT Board Placement. CT Board Placement assists cannabis industry clients in identifying and recruiting candidates for Board of Director positions who have a diverse blend of skills and experience that match the strategic direction of each client.
"Appointing the right non-executive directors is a critically important decision for all cannabis companies in today's competitive marketplace," said Liesl Bernard, CEO of CannabizTeam. "Recruiting directors in the cannabis space is a more complex process due to the relative youth of the industry and the lingering legacy legal nuances. Our goal with CT Board Placement is to help our clients find a diverse blend of candidates with relevant experience, strong character and reputation, proven judgment and leadership skills that will set them up for future success."
Board of Director diversity reflects one of the core values of CT Board Placement, which is especially relevant as the cannabis industry has continued to lead corporate America in social equity and corporate social responsibility programs. CannabizTeam is committed to promoting fairness, justice and equity in the cannabis industry, and will work to fill Board of Director positions with individuals of all genders, religions and races.
CT Board Placement will also offer a Cannabis Director Development Program to help first-time directors learn the culture and nuances of the company they will serve as well as the broader cannabis industry. The Cannabis Director Development Program includes a detailed curriculum exploring the most relevant governance issues in North America, with a special focus on issues facing boards in the U.S., Canadian and Mexican cannabis markets.
CT Board Placement is a division of CannabizTeam Worldwide, which also operates CT Executive Search, CannabizTeam Direct Hire and CannabizTemp. Through its four staffing divisions, CannabizTeam fills more than 1,000 cannabis positions each year in all verticals of the industry across the globe. CannabizTeam's proprietary database includes more than 100,000 successful executives with experience in and beyond the cannabis industry - an excellent resource for cannabis companies searching to fill Board of Director positions.
To learn more about CT Board Placement, visit: https://cannabizteam.com/cannabis-board-of-directors-recruitment/.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android